Literature DB >> 17028241

Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.

Meredith T Morris1, Courtney DeBruin, Zhaoqing Yang, Jeremy W Chambers, Kerry S Smith, James C Morris.   

Abstract

Trypanosoma brucei expresses two hexokinases that are 98% identical, namely, TbHK1 and TbHK2. Homozygous null TbHK2-/- procyclic-form parasites exhibit an increased doubling time, a change in cell morphology, and, surprisingly, a twofold increase in cellular hexokinase activity. Recombinant TbHK1 enzymatic activity is similar to that of other hexokinases, with apparent Km values for glucose and ATP of 0.09 +/- 0.02 mM and 0.28 +/- 0.1 mM, respectively. The k(cat) value for TbHK1 is 2.9 x 10(4) min(-1). TbHK1 can use mannose, fructose, 2-deoxyglucose, and glucosamine as substrates. In addition, TbHK1 is inhibited by fatty acids, with lauric, myristic, and palmitic acids being the most potent (with 50% inhibitory concentrations of 75.8, 78.4, and 62.4 microM, respectively). In contrast to TbHK1, recombinant TbHK2 lacks detectable enzymatic activity. Seven of the 10 amino acid differences between TbHK1 and TbHK2 lie within the C-terminal 18 amino acids of the polypeptides. Modeling of the proteins maps the C-terminal tails near the interdomain cleft of the enzyme that participates in the conformational change of the enzyme upon substrate binding. Replacing the last 18 amino acids of TbHK2 with the corresponding residues of TbHK1 yields an active recombinant protein with kinetic properties similar to those of TbHK1. Conversely, replacing the C-terminal tail of TbHK1 with the TbHK2 tail inactivates the enzyme. These findings suggest that the C-terminal tail of TbHK1 is important for hexokinase activity. The altered C-terminal tail of TbHK2, along with the phenotype of the knockout parasites, suggests a distinct function for the protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028241      PMCID: PMC1694814          DOI: 10.1128/EC.00146-06

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  30 in total

1.  Regulation of phosphotransferase activity of hexokinase 2 from Saccharomyces cerevisiae by modification at serine-14.

Authors:  R Golbik; M Naumann; A Otto; E Müller; J Behlke; R Reuter; G Hübner; T M Kriegel
Journal:  Biochemistry       Date:  2001-01-30       Impact factor: 3.162

2.  Hexokinase PII: structural analysis and glucose signalling in the yeast Saccharomyces cerevisiae.

Authors:  I Mayordomo; P Sanz
Journal:  Yeast       Date:  2001-07       Impact factor: 3.239

3.  The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae.

Authors:  A Rodríguez; T De La Cera; P Herrero; F Moreno
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

4.  Proline metabolism in procyclic Trypanosoma brucei is down-regulated in the presence of glucose.

Authors:  Nadia Lamour; Loïc Rivière; Virginie Coustou; Graham H Coombs; Michael P Barrett; Frédéric Bringaud
Journal:  J Biol Chem       Date:  2005-01-21       Impact factor: 5.157

5.  One-step purification of a fully active hexahistidine-tagged human hexokinase type I overexpressed in Escherichia coli.

Authors:  F Palma; S Longhi; D Agostini; V Stocchi
Journal:  Protein Expr Purif       Date:  2001-06       Impact factor: 1.650

6.  Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters.

Authors:  Z Wang; J C Morris; M E Drew; P T Englund
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

7.  Long chain fatty acids inhibit and medium chain fatty acids activate mammalian cardiac hexokinase.

Authors:  J M Stewart; J A Blakely
Journal:  Biochim Biophys Acta       Date:  2000-04-12

8.  Molecular and biochemical characterization of hexokinase from Trypanosoma cruzi.

Authors:  Ana Judith Cáceres; Ramon Portillo; Hector Acosta; David Rosales; Wilfredo Quiñones; Luisana Avilan; Leiria Salazar; Michel Dubourdieu; Paul A M Michels; Juan Luis Concepción
Journal:  Mol Biochem Parasitol       Date:  2003-02       Impact factor: 1.759

9.  Sequencing, modeling, and selective inhibition of Trypanosoma brucei hexokinase.

Authors:  Michèle Willson; Yves Henri Sanejouand; Jacques Perie; Véronique Hannaert; Fred Opperdoes
Journal:  Chem Biol       Date:  2002-07

10.  Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library.

Authors:  James C Morris; Zefeng Wang; Mark E Drew; Paul T Englund
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

View more
  19 in total

1.  Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1.

Authors:  Heidi C Dodson; Todd A Lyda; Jeremy W Chambers; Meredith T Morris; Kenneth A Christensen; James C Morris
Journal:  Exp Parasitol       Date:  2010-11-11       Impact factor: 2.011

2.  Environmentally regulated glycosome protein composition in the African trypanosome.

Authors:  Sarah Bauer; James C Morris; Meredith T Morris
Journal:  Eukaryot Cell       Date:  2013-05-24

3.  Glycerol 3-phosphate alters Trypanosoma brucei hexokinase activity in response to environmental change.

Authors:  Heidi C Dodson; Meredith T Morris; James C Morris
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

4.  Extra-glycosomal localisation of Trypanosoma brucei hexokinase 2.

Authors:  April C Joice; Todd L Lyda; Andrew C Sayce; Emilie Verplaetse; Meredith T Morris; Paul A M Michels; Derrick R Robinson; James C Morris
Journal:  Int J Parasitol       Date:  2012-04       Impact factor: 3.981

5.  Molecular and biochemical characterization of Eimeria tenella hexokinase.

Authors:  Mingfei Sun; Shenquan Liao; Longxian Zhang; Caiyan Wu; Nanshan Qi; Minna Lv; Juan Li; Xuhui Lin; Jianfei Zhang; Mingquan Xie; Guan Zhu; Jianping Cai
Journal:  Parasitol Res       Date:  2016-05-06       Impact factor: 2.289

Review 6.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

7.  Assembly of heterohexameric trypanosome hexokinases reveals that hexokinase 2 is a regulable enzyme.

Authors:  Jeremy W Chambers; Margaret T Kearns; Meredith T Morris; James C Morris
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

8.  A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity.

Authors:  Elizabeth R Sharlow; Todd A Lyda; Heidi C Dodson; Gabriela Mustata; Meredith T Morris; Stephanie S Leimgruber; Kuo-Hsiung Lee; Yoshiki Kashiwada; David Close; John S Lazo; James C Morris
Journal:  PLoS Negl Trop Dis       Date:  2010-04-13

9.  Interrogating a hexokinase-selected small-molecule library for inhibitors of Plasmodium falciparum hexokinase.

Authors:  Michael T Harris; Dawn M Walker; Mark E Drew; William G Mitchell; Kevin Dao; Chad E Schroeder; Daniel P Flaherty; Warren S Weiner; Jennifer E Golden; James C Morris
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

10.  Optimization and Evaluation of Antiparasitic Benzamidobenzoic Acids as Inhibitors of Kinetoplastid Hexokinase 1.

Authors:  Daniel P Flaherty; Michael T Harris; Chad E Schroeder; Haaris Khan; Elizabeth W Kahney; Amber L Hackler; Stephen L Patrick; Warren S Weiner; Jeffrey Aubé; Elizabeth R Sharlow; James C Morris; Jennifer E Golden
Journal:  ChemMedChem       Date:  2017-11-16       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.